Position in AXSM
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$119,202
+$26,242 QoQ
Shares Held
487
-11.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#418
of 500 holders
Holding Since
Jun 2021
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIRST HORIZON CORP holds $7,150,431 across 40 Biotechnology names. AXSM ranks #4 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,201 | $5,563,871 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
615 | $383,476 | |
| 3 | TVTX |
Travere Therapeutics, Inc.
|
2,161 | $122,765 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
This page
|
487 | $119,202 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
297 | $93,877 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,190 | $93,140 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,088 | $88,682 | |
| 8 | INSM |
INSMED Inc
|
708 | $75,486 |
All Filings in AXSM
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $119,202 | 487 | Shares | Defined | 2026-07-20 | |
| 2026-03-31 | $92,960 | 550 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $109,765 | 601 | Shares | Defined | 2026-01-27 | |
| 2025-09-30 | $33,520 | 276 | Shares | Defined | 2025-10-27 | |
| 2021-06-30 | $876 | 13 | Shares | Defined | 2021-08-09 | |
| No filing history on record for this holder in this stock. | ||||||